Data as of Jul 23
| +0.14 / +2.61%|
The 3 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 7.00. The median estimate represents a +45.19% increase from the last price of 5.51.
The current consensus among 4 polled investment analysts is to Hold stock in Pacific Biosciences of California Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.